Literature DB >> 3132066

Recurrent seizures following mucosal application of TAC.

M R Daya1, B T Burton, M R Schleiss, J H DiLiberti.   

Abstract

A 5-year-old 20-kg boy developed grand mal seizures following application of 2 mL of tetracaine-adrenalin-cocaine to an oral mucosa laceration. Diazepam 6 mg IV followed by 195 mg phenobarbital was required to terminate the seizures. The patient was transferred to a pediatric intensive care unit for further evaluation and treatment. A toxicology screen obtained after transfer was positive only for diazepam and phenobarbital. The child remained lethargic for several hours but otherwise had a normal neurological examination. Brain computed tomography was normal. Anticonvulsant medication was discontinued prior to discharge and the child had no subsequent seizures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132066     DOI: 10.1016/s0196-0644(88)80409-8

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  6 in total

1.  Is cocaine needed in topical anaesthesia?

Authors:  S Bush
Journal:  Emerg Med J       Date:  2002-09       Impact factor: 2.740

Review 2.  Clinical toxicology of cocaine.

Authors:  K A Loper
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 May-Jun

Review 3.  Topical anaesthetics for pain control during repair of dermal laceration.

Authors:  Baraa O Tayeb; Anthony Eidelman; Cristy L Eidelman; Ewan D McNicol; Daniel B Carr
Journal:  Cochrane Database Syst Rev       Date:  2017-02-22

Review 4.  Benefit and risks of local anesthetics in infants and children.

Authors:  Joel B Gunter
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Topical anesthesia.

Authors:  P D Keyes; J M Tallon; J Rizos
Journal:  Can Fam Physician       Date:  1998-10       Impact factor: 3.275

6.  Acute wound management: revisiting the approach to assessment, irrigation, and closure considerations.

Authors:  Bret A Nicks; Elizabeth A Ayello; Kevin Woo; Diane Nitzki-George; R Gary Sibbald
Journal:  Int J Emerg Med       Date:  2010-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.